Human papillomavirus infection and primary fallopian tube carcinoma: A seroepidemiological study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 4, 2007, Pages 425-429

  Riska, A ^a   Finne, P ^a   Koskela, P ^b   Alfthan, H ^a   Jalkanen, J ^a   Lehtinen, M ^b   Sorvari, T ^a   Stenman, U H ^a   Paavonen, J ^a   Leminen, A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Chlamydia trachomatis; Herpes simplex virus type 2; Human papillomavirus; Primary fallopian tube carcinoma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; STATISTICAL ANALYSIS; UTERINE TUBE; UTERINE TUBE CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 33847776527     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01256.x     Document Type: Article

References (34)

1. Nordin AJ. Primary carcinoma of the fallopian tube: a 20-year literature review. Obstet Gynecol Surv 1994;49:349-61.
2. Riska A, Leminen A, Pukkala E. Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97. Int J Cancer 2003;104:643-5.
3. Zimna K, Poreba E, Kedzia W, Gozdzicka-Jozefiak A, Kedzia H. Human papillomavirus (HPV) in upper genital tract carcinomas of women. Eur J Gynaecol Oncol 1997;18:415-17.
4. Chen TR, Chan PJ, Seraj IM, King A. Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma. Gynecol Oncol 1999;72:180-2.
5. Hisada M, van den Berg BJ, Strickler HD, Christianson RE, Wright WE, Waters DJ, et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control 2001;12:335-41.
6. Di Felice V, David S, Cappello F, Farina F, Zummo G. Is chlamydial heat shock protein 60 a risk factor for oncogenesis? Cell Mol Life Sci 2005;62:4-9.
7. Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ, Ke Y. Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer 2003;89:672-5.
8. zur Hausen H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994;343:955-7.
9. Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, et al. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. Br J Cancer 2002;87:175-80.
10. Heselmeyer K, Hellström AC, Blegen H, Schrock E, Silfverward C, Shah K, et al. Primary carcinoma of the fallopian tube: comparative genomic hybridization reveals high genetic instability and a specific, recurring pattern of chromosomal aberrations. Int J Gynecol Pathol 1998;17:245-54.
11. Dillner J, Kallings I, Brihmer C, Sikstrom B, Koskela P, Lehtinen M, et al. Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to chlamydia trachomatis are markers of sexual behavior. J Infect Dis 1996;173:1394-8.
12. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, et al. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997;89:1293-9.
13. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994;86:494-9.
14. Kjellberg L, Wang Z, Wiklund F, Edlund K, Ångström T, Lenner P, et al. Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study. J Gen Virol 1999;80:391-8.
15. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol 1999;9:423-30.
16. Närvänen A, Puolakkainen M, Hao W, Kino K, Suni J. Detection of antibodies to chlamydia trachomatis with peptide based species specific EIA. Infect Dis Obstet Gynecol 1998;5:349-54.
17. Sanchez-Martinez D, Schmid DS, Whittington W, Brown D, Reeves WC, Chatterjee S, et al. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis 1991;164:1196-9.
18. van de Laar MJ, Termorshuizen F, Slomka MJ, van Doornum GJ, Ossewaarde JM, Brown DW, et al. Prevalence and correlates of herpes simplex virus type 2 infection: Evaluation of behavioral risk factors. Int J Epidemiol 1998;27:127-34.
19. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al. Evidence for chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in brazil and the Philippines. J Infect Dis 2002;185:324-31.
20. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edn. New York, NY: John Wiley & Sons, 2000.
21. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-802.
22. Madeleine MM, Daling JR, Carter JJ, Wipf GC, Schwartz SM, McKnight B, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997;89:1516-23.
23. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263-70.
24. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
25. Kaufman RH, Bornstein J, Gordon AN, Adam E, Kaplan AL, Adler-Storthz K. Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma. Gynecol Oncol 1987;27:340-9.
26. Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC, Ngan HY. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol 2002;87:104-11.
27. Yang HJ, Liu VW, Tsang PC, Yip AM, Ng TY, Cheung AN, et al. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development. Tumour Biol 2003;24:310-16.
28. Czerwenka K, Lu Y, Heuss F, Manavi M, Kubista E. Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol Oncol 1996;61:210-14.
29. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 2000;83:561-5.
30. Clayton NL, Jaaback KS, Hirschowitz L. Primary fallopian tube carcinoma - the experience of a UK cancer centre and a review of the literature. J Obstet Gynaecol 2005;25:694-702.
31. Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Trope CG, Abeler VM. Carcinoma of the fallopian tube. Cancer 2000;89:2076-84.
32. Hellstrom AC, Silfversward C, Nilsson B, Pettersson F. Carcinoma of the fallopian tube. A clinical and histopathologic review. The radium-hemmet series. Int J Gynecol Cancer 1994;4:395-400.
33. Gungor T, Keskin HL, Zergeroglu S, Keskin EA, Yalcin H, Aydogdu T, et al. Tuberculous salpingitis in two of five primary fallopian tube carcinomas. J Obstet Gynaecol 2003;23:193-5.
34. Riska A, Finne P, Alfthan H, Anttila T, Jalkanen J, Sorvari T, et al. Chlamydial infection and primary fallopian tube carcinoma. Eur J Cancer 2006;42:1835-8.